Stay updated on Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.

Latest updates to the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe bottom revision tag updates from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Contacts/Locations and Study Status sections to the record history, reflecting updated site details and current trial status. The latest version shows these updates in the study record and status history.SummaryDifference0.3%

- Check39 days agoChange Detected- Added Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedThe record history now shows an addition of Revision: v3.4.3 and a deletion of Revision: v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedA new page revision entry 'Revision: v3.4.2' was added to the history, and the previous funding-lapse notice and 'Revision: v3.4.1' were removed.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice about government funding and a version update to v3.4.1 (replacing v3.4.0) were added. These changes do not affect trial data or navigation on the record page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.